Firstly, genetic variation, particularly in the PNPLA3 gene, has been shown to contribute to differences in hepatic fat content and susceptibility to NAFLD [34–36]. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.